AstraZeneca shares dive as European countries suspend use of vaccine

Vaccine withdrawn by Denmark, Norway and Iceland as a ‘precaution’

Denmark, Norway and Iceland have halted the Oxford/AstraZeneca vaccine after a Danish women died with blood clots after receiving a jab.

The EU medicines agency stated that there is no indication the jab had caused the blood clots.

AstraZeneca confirmed in a statement that the drug had been studied extensively.

“Patient Safety is the highest priority for AstraZeneca. Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes Covid-19 Vaccine AstraZeneca.” Peer-reviewed data confirmed it had been “generally well tolerated”, the statement added.

The news emerging comes as a set back for the continent’s vaccination push that had recently gained momentum.

- Advertisement -

AstraZeneca’s share price fell by 2.52% on Thursday to 7,011p as the news broke.

Latest

Related Articles

Tagdiv Cloud library - template content.